...
机译:在经过复发或难治性AML的患者中使用低甲基化试剂后的同种异体造血干细胞移植:来自国际回顾性研究的结果
Department of Internal Medicine Section of Hematology Yale University School of Medicine;
Department of Biostatistics Yale School of Public Health;
Department of Medicine Hospital Universitario y Politécnico de La Fe University of Valencia;
Saint-Louis Hospital University Paris 7;
Division of Hematology and Oncology Weill Cornell Medicine and The New York Presbyterian Hospital;
Leukemia Program Cleveland Clinic;
Leukemia Program Cleveland Clinic;
Leukemia Program Cleveland Clinic;
Department of Internal Medicine Section of Hematology Yale University School of Medicine;
Massachusetts General Hospital Cancer Center Harvard Medical School;
Department of Malignant Hematology Moffitt Cancer Center and Research Institute;
Division of Hematology/Oncology University of Nebraska Medical Center;
Division of Hematology Mayo Clinic;
C?te d'Azur University Nice Sophia Antipolis University CHU of Nice;
Division of Hematology University of Florence;
Division of Hematology and Oncology Weill Cornell Medicine and The New York Presbyterian Hospital;
Saint-Louis Hospital University Paris 7;
Division of Hematology Mayo Clinic;
Massachusetts General Hospital Cancer Center Harvard Medical School;
Department of Pharmacy Yale New Haven Hospital;
Department of Internal Medicine Section of Hematology Yale University School of Medicine;
Department of Internal Medicine Section of Hematology Yale University School of Medicine;
Department of Hematology Institut Paoli Calmettes;
Division of Hematology/Oncology University of Nebraska Medical Center;
Department of Hematology Oncology and Clinical Immunology Heinrich-Heine-University Düsseldorf;
Division of Hematology/Oncology Hospital San Pedro Alcántara;
Division of Hematology/Oncology University Hospital Reina Sofía;
Department of Internal Medicine Section of Hematology Yale University School of Medicine;
Department of Internal Medicine Section of Hematology Yale University School of Medicine;
Survival; Hypomethylating agents; Transplant; AML;
机译:在经过复发或难治性AML的患者中使用低甲基化试剂后的同种异体造血干细胞移植:来自国际回顾性研究的结果
机译:异种造血干细胞移植与骨髓增生综合征患者的低甲基化试剂:回顾性案例对照研究
机译:同种异体干细胞移植(allo-SCT)后发生骨髓增生异常综合症(MDS)或急性骨髓性白血病(AML)复发的患者,用次甲基化剂(HMA)和/或来那度胺(len)进行挽救疗法
机译:循环肿瘤DNA预测AML和MDS中的同种异体造血干细胞移植
机译:接受同种异体造血干细胞移植的患者的供体选择:加拿大造血干细胞移植医生的优先事项评估。
机译:异基因造血干细胞移植与骨髓增生异常综合征去甲基化药物:回顾性病例对照研究
机译:在经过复发或难治性AML的患者中使用低甲基化试剂后的同种异体造血干细胞移植:来自国际回顾性研究的结果